EYPT Stock Analysis: Buy, Sell, or Hold?
EYPT - EyePoint Pharmaceuticals, Inc. Common Stock
$13.27
-0.25 (-1.89%)
▼
5d:
-14.14%
30d:
-27.39%
90d:
+8.64%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 04, 2026
29d
Get Alerted When EYPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EYPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EYPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EYPT is currently trading at $13.27, which is considered oversold relative to its 30-day fair value range of $14.83 to $17.51.
Technical Outlook: Technically, EYPT is in a strong uptrend. The price is currently testing key support at $13.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EYPT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $36.08 (+166.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EYPT is in a strong uptrend. The price is currently testing key support at $13.08. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EYPT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $36.08 (+166.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$14.83 -
$17.51
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 166.9% below Wall St target ($36.08)
- CAUTION: 5-day price weakness (-14.1%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$14.83 -
$17.51
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$13.08
Resistance Level
$16.73
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.79
Wall Street Target
$36.08
(+166.9%)
Revenue Growth (YoY)
-90.8%
Last updated: February 02, 2026 2:44 PM ET
Data refreshes hourly during market hours. Next update: 3:44 PM
Data refreshes hourly during market hours. Next update: 3:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EYPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 50 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 63 BUY |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 48 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 54 HOLD |
